Amphastar Pharmaceuticals, Inc. (AMPH)
20.23
-6.26
(-23.63%)
USD |
NASDAQ |
Feb 27, 16:00
20.27
+0.04
(+0.20%)
Pre-Market: 09:18
Amphastar Pharmaceuticals Research and Development Expense (TTM) : 71.24M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Pfizer Inc. | 10.25B |
| Organon & Co. | 366.00M |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| CorMedix, Inc. | 12.46M |